Does ABROCITINIB Cause Off label use? 269 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 269 reports of Off label use have been filed in association with ABROCITINIB (CIBINQO). This represents 8.5% of all adverse event reports for ABROCITINIB.
269
Reports of Off label use with ABROCITINIB
8.5%
of all ABROCITINIB reports
1
Deaths
17
Hospitalizations
How Dangerous Is Off label use From ABROCITINIB?
Of the 269 reports, 1 (0.4%) resulted in death, 17 (6.3%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABROCITINIB. However, 269 reports have been filed with the FAERS database.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Therapeutic product effect incomplete (186)
Pruritus (171)
Rash (134)
Nausea (130)
Dermatitis atopic (110)
Headache (85)
Acne (73)
Fatigue (70)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ABROCITINIB Alternatives Have Lower Off label use Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL